SCHEMBL3717033

SCHEMBL3717033

Cc1ccccc1P(c1ccccc1C)c1ccccc1C.c1ccc(P(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.57
TDP1 Q9NUW8 2/20 0.57
ESR1 P03372 4/20 0.44
ESR2 Q92731 4/20 0.44
ACHE P22303 3/20 0.41
TSHR P16473 2/20 0.41
DRD1 P21728 2/20 0.39
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
ALDH1A1 P00352 2/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
LMNA P02545 1/20 0.33
ALOX12 P18054 1/20 0.33
ALKBH5 Q6P6C2 1/20 0.32
FTO Q9C0B1 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP2A6 P11509 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16018463 0.93 CYP3A4 (0.48) CYP3A4TDP1ESR1ESR2ACHE
SCHEMBL49618 0.93 CYP3A4 (0.52) CYP3A4TDP1ESR1ESR2ACHE
SCHEMBL29535212 0.93 CYP3A4 (0.52) CYP3A4TDP1ESR1ESR2ACHE
SCHEMBL49858 0.93 CYP3A4 (0.52) CYP3A4TDP1ESR1ESR2ACHE
Carbon Tetrachloride SCHEMBL8131261 0.92 CYP3A4 (0.48) CYP3A4TDP1ESR1ESR2ACHE
SCHEMBL31531976 0.91 CYP3A4 (0.50) CYP3A4TDP1ESR1ESR2ACHE
Hydrochloric Acid SCHEMBL31198728 0.91 CYP3A4 (0.50) CYP3A4TDP1ESR1ESR2ACHE
Hydrochloric Acid SCHEMBL11571801 0.91 CYP3A4 (0.50) CYP3A4TDP1ESR1ESR2ACHE
Bromide SCHEMBL30317742 0.91 CYP3A4 (0.50) CYP3A4TDP1ESR1ESR2ACHE
Iodide SCHEMBL30903480 0.91 CYP3A4 (0.50) CYP3A4TDP1ESR1ESR2ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0751207-B1 Fluorosilicone formulations DOW CORNING (US) 2001-10-10 EP claimed
EP-3071619-B1 ADHESIVE COMPOSITION ROHM & HAAS (US) 2021-12-01 EP disclosed
EP-3036268-B1 ADHESIVE COMPOSITION ROHM & HAAS (US) 2020-04-01 EP disclosed
EP-3071620-B1 EPOXY-TERMINATED POLYESTER ROHM & HAAS (US) 2019-07-17 EP disclosed
EP-3071621-B1 EPOXY-TERMINATED POLYESTER ROHM & HAAS (US) 2019-07-03 EP disclosed
EP-2688944-B2 RESIN COMPOSITIONS FOR THERMOSETTING POWDER COATING COMPOSITIONS DSM IP ASSETS BV (NL) 2017-12-20 EP disclosed
US-9751977-B2 Epoxy-terminated polyester ROHM AND HAAS COMPANY (US) 2017-09-05 US disclosed
US-9752066-B2 Adhesive composition ROHM AND HAAS COMPANY (US) 2017-09-05 US disclosed
US-9701786-B2 EPOXY-terminated polyester ROHM AND HAAS COMPANY (US) 2017-07-11 US disclosed
US-9701787-B2 Adhesive composition ROHM AND HAAS COMPANY (US) 2017-07-11 US disclosed
EP-2688944-B1 RESIN COMPOSITIONS FOR THERMOSETTING POWDER COATING COMPOSITIONS DSM IP ASSETS BV (NL) 2014-06-25 EP disclosed
EP-2688944-A1 RESIN COMPOSITIONS FOR THERMOSETTING POWDER COATING COMPOSITIONS DSM IP Assets B.V. (NL) 2014-01-29 EP disclosed
US-8541420-B2 Ketolide compounds having antimicrobial activity WOCKHARDT LTD. (IN) 2013-09-24 US disclosed
WO-2012130722-A1 RESIN COMPOSITIONS FOR THERMOSETTING POWDER COATING COMPOSITIONS DSM IP ASSETS B.V. (NL) 2012-10-04 WO disclosed
US-20120142710-A1 Ketolide Compounds Having Antimicrobial Activity WOCKHARDT LIMITED (IN) 2012-06-07 US disclosed
WO-2010136971-A1 KETOLIDE COMPOUNDS HAVING ANTIMICROBIAL ACTIVITY WOCKHARDT RESEARCH CENTRE (IN) 2010-12-02 WO disclosed
EP-1523473-A1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-04-20 EP disclosed
WO-2004009547-A1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-01-29 WO disclosed
EP-1303563-A1 MIXTURES OF PHOSPHORUS-CONTAINING COMPOUNDS USED AS POLYMER STABILISERS Clariant Finance (BVI) Limited (VG) 2003-04-23 EP disclosed
WO-2002006390-A1 MIXTURES OF PHOSPHORUS-CONTAINING COMPOUNDS USED AS POLYMER STABILIZERS CLARIANT FINANCE (BVI) LIMITED (VG) 2002-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142710-A1 Ketolide Compounds Having Antimicrobial Activity CYP51A1, AKR1A1, AKR1C1 CYP3A4 290/4885TDP1 3917/4885ESR1 3563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.